1. Home
  2. RGNX vs NPK Comparison

RGNX vs NPK Comparison

Compare RGNX & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • NPK
  • Stock Information
  • Founded
  • RGNX 2008
  • NPK 1905
  • Country
  • RGNX United States
  • NPK United States
  • Employees
  • RGNX N/A
  • NPK N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • NPK Ordnance And Accessories
  • Sector
  • RGNX Health Care
  • NPK Industrials
  • Exchange
  • RGNX Nasdaq
  • NPK Nasdaq
  • Market Cap
  • RGNX 459.1M
  • NPK 539.8M
  • IPO Year
  • RGNX 2015
  • NPK N/A
  • Fundamental
  • Price
  • RGNX $9.18
  • NPK $76.81
  • Analyst Decision
  • RGNX Strong Buy
  • NPK
  • Analyst Count
  • RGNX 12
  • NPK 0
  • Target Price
  • RGNX $36.36
  • NPK N/A
  • AVG Volume (30 Days)
  • RGNX 886.8K
  • NPK 33.2K
  • Earning Date
  • RGNX 11-06-2024
  • NPK 11-08-2024
  • Dividend Yield
  • RGNX N/A
  • NPK 1.29%
  • EPS Growth
  • RGNX N/A
  • NPK 43.29
  • EPS
  • RGNX N/A
  • NPK 4.76
  • Revenue
  • RGNX $84,327,000.00
  • NPK $351,952,000.00
  • Revenue This Year
  • RGNX $7.91
  • NPK N/A
  • Revenue Next Year
  • RGNX $214.75
  • NPK N/A
  • P/E Ratio
  • RGNX N/A
  • NPK $15.88
  • Revenue Growth
  • RGNX N/A
  • NPK N/A
  • 52 Week Low
  • RGNX $8.54
  • NPK $69.58
  • 52 Week High
  • RGNX $28.80
  • NPK $86.08
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 43.02
  • NPK 54.38
  • Support Level
  • RGNX $8.87
  • NPK $74.53
  • Resistance Level
  • RGNX $12.11
  • NPK $79.86
  • Average True Range (ATR)
  • RGNX 0.96
  • NPK 1.73
  • MACD
  • RGNX -0.05
  • NPK -0.01
  • Stochastic Oscillator
  • RGNX 17.17
  • NPK 56.11

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments viz Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: